[
  {
    "ts": null,
    "headline": "A Fresh Look at Medtronic (MDT) Valuation After FDA Green Light for Altaviva Neuromodulation Device",
    "summary": "Medtronic (MDT) just grabbed headlines with FDA approval for its Altaviva device, a minimally invasive implantable treatment for urge urinary incontinence. What sets Altaviva apart? The tiny device delivers therapy automatically near the ankle, comes with a 15-year battery life, MRI compatibility, and is ready to work before a patient even heads home from their procedure. For investors, this moment signals more than just a new product. It serves as a reminder of Medtronic’s longstanding...",
    "url": "https://finnhub.io/api/news?id=775ed459b3dc49cc34036a50f48258cee18b0427355ecb6a39bf0e2f2c30202d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759056979,
      "headline": "A Fresh Look at Medtronic (MDT) Valuation After FDA Green Light for Altaviva Neuromodulation Device",
      "id": 136907555,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (MDT) just grabbed headlines with FDA approval for its Altaviva device, a minimally invasive implantable treatment for urge urinary incontinence. What sets Altaviva apart? The tiny device delivers therapy automatically near the ankle, comes with a 15-year battery life, MRI compatibility, and is ready to work before a patient even heads home from their procedure. For investors, this moment signals more than just a new product. It serves as a reminder of Medtronic’s longstanding...",
      "url": "https://finnhub.io/api/news?id=775ed459b3dc49cc34036a50f48258cee18b0427355ecb6a39bf0e2f2c30202d"
    }
  }
]